Bladder Cancer Clinical Updates and Highlights from ASCO GU 2024
Dana-Farber Cancer Institute via YouTube
Build GenAI Apps from Scratch — UCSB PaCE Certificate Program
You’re only 3 weeks away from a new language
Overview
AI, Data Science & Cloud Certificates from Google, IBM & Meta — 40% Off
One plan covers every Professional Certificate on Coursera. 40% off Coursera Plus Annual.
Unlock All Certificates
Watch a comprehensive clinical update presentation from Dana-Farber Cancer Institute's Lank Center for Genitourinary Oncology covering the latest bladder cancer research findings and trial results from ASCO GU 2024. Learn about key developments including the Ambassador Trial, EV32 Trial, and UPF Front Trial, gaining valuable insights into the latest advancements in bladder cancer treatment and clinical outcomes. Explore detailed analysis and expert commentary on these significant trials that are shaping the future of genitourinary oncology in this 23-minute educational session.
Syllabus
Intro
Ambassador Trial
EV32 Trial
UPF Front Trial
Comments
Taught by
Dana-Farber Cancer Institute